IR Site Map PRINT For Our Shareholders and Investors IR News IR Library Financial Results and IR Events Financial results, supplementary documents, financial results presentation materials, and IR event materials (including R&D Presentation) available. Annual Securities Report This document discloses company details prepared for each fiscal year in accordance with the Financial Instruments and Exchange Act. Integrated Report The Company annually provides its management strategy and ESG information along with a corporate message from its executives. Fact Sheet Fact sheets and data sheets are available. Medium-Term Management Plan (Related links) Details of the company’s Medium-Term Management Plan are available. Corporate Governance Report(Related links) Corporate Governance Reports are available. Internal Control Report (Related links) (Japanese version only) Internal Control Reports are available. Stock and Shareholder Information (Related links) Information on stock price, dividends, general meeting of shareholders, etc. IR Calendar Management Strategies and Policies Mid-Term Management Plan The Company’s medium- to long-term management strategies Pipeline and Intellectual Property Pipeline status of the Company’s subsidiary, ASKA Pharmaceutical Business Risks Matters related to business conditions and accounting conditions that may have a significant impact on investors’ decisions. Disclosure policy Our Disclosure policy to provide timely and appropriate information IR Basic Policy Our IR basic policy is posted here. Disclaimer Disclaimer regarding this website. Governance The Group's objective is to attain sustainable growth for the Company and its subsidiaries while improving its corporate value in the medium to long term. To achieve this goal, the Group is consistently working on establishing and reinforcing a robust and influential corporate governance system. Basic Principles/Corporate Governance Structure Corporate Governance Basic Policy Corporate Governance Report Board Members Compliance / Risk Management Internal Control System Internal Control Report (Japanese version only) Dialogue with Shareholders Message from Outside Directors Financial Highlights Performance Review Reviews of recent business performance and future outlook of the Company are available here. Performance Highlights Graphs and numerical data on Sales, Operating profit, and other key financial figures are available here. Financial Conditions Graphs and numerical data on total assets, net assets, and other major financial figures are available here. Financial Statements Balance sheets, income statements, and cash flow statements are available here. Earnings Forecast Information on our business forecasts is available here. For Individual Investors Point1 About ASKA -Understanding & History– The history of ASKA Pharmaceutical, from its founding in 1893 to the present, is introduced here with photos. Point2 About ASKA -Strengths- ASKA Pharmaceutical’s strength comes from its high level of specialization in the three therapeutic areas of internal medicine, obstetrics and gynecology, and urology. Point3 Highly specialized product lineup Major products in internal medicine, obstetrics & gynecology, and urology are introduced here. Point4 Continuously evolving R&D Aiming to continuously create innovative new drugs with high value, we are working to strengthen our R&D capabilities. Point5 Stable Shareholder Returns We regard the return of profits to shareholders as an important management issue and pay stable dividends. Frequently Asked Questions Frequently asked questions from shareholders and investors are summarized here. Business Model An easy-to-understand overview of the pharmaceutical business model. ASKA’s Management Strategy A clear explanation of our corporate management strategy. Medicine & Body Glossary A simple guide to women’s health, body functions, and related medicines. IR seminar for Individual Investors Key facts and figures about ASKA Pharmaceutical Holdings presented clearly for individual investors. ASKA Pharmaceutical Holdings in Numbers (Related Link) An easy-to-understand overview of ASKA Pharmaceutical Holdings through key figures. Sustainability (Related Link) Introducing our initiatives on ESG and the SDGs. IR Related Information IR Site Map Recommended Route to Access Our IR Website How to Use the IR Site IR Inquiries External Evaluation (IR) Stock and Shareholder Information Stock summary information This section provides basic information about the Company's shares and shareholder procedures. Shareholder Information Top 10 Shareholders and Distribution of Shares. Shareholders’ Meeting The date, time, and the venue of the general meeting of shareholders, and the materials available to them are posted. Stock Price Information Stock chart, stock price search, and investment calculator services are available. Shareholder Return Dividend policy and dividends are available here. Cross-Shareholdings This page provides information on the Company's policy for reducing cross-shareholdings and a list of shares currently held. Articles of Incorporation and Stock Handling Regulations (Japanese version only) Articles of Incorporation and Stock Handling Regulations. Analyst Coverage List of analysts covering the Company. Corporate Bonds and Ratings Information Corporate Bonds and Ratings Information Shareholder Newsletters (Japanese version only) Shareholder Newsletters Privacy Policy (Shareholders) Privacy Policy (Shareholders) Electronic Public Notice (Japanese version only) Disclaimer ESG Chart and ESG Data Book (Related Links)